CAPTRUST Financial Advisors
AVXL icon

CAPTRUST Financial Advisors’s Anavex Life Sciences AVXL Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$10K – 2232
2022
Q2 		$10K Hold
1,000
– – ﹤0.01% 3734
2022
Q1 		$12K Sell
1,000
-23
-2% -$283 ﹤0.01% 3691
2021
Q4 		$18K Buy
1,023
+23
+2% +$437 ﹤0.01% 3345
2021
Q3 		$18K Sell
1,000
-427
-30% -$8.5K ﹤0.01% 3218
2021
Q2 		$33K Sell
1,427
-2,017
-59% -$29.9K ﹤0.01% 2768
2021
Q1 		$51K Buy
3,444
+1,944
+130% +$21.2K ﹤0.01% 2412
2020
Q4 		$8K Hold
1,500
– – ﹤0.01% 2650
2020
Q3 		$6K Hold
1,500
– – ﹤0.01% 2458
2020
Q2 		$8K Buy
+1,500
New +$5.67K ﹤0.01% 2246

Other funds holding AVXL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return